The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses

Journal of Virology

Volumn 88, Issue 23, 2014, Pages 13811-13820

  Russier, Marion ^a,b,c   Reynard, Stéphanie ^a,b   Carnec, Xavier ^a,b   Baize, Sylvain ^a,b  

^a Institut Pasteur   (France)

^b CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXONUCLEASE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; MESSENGER RNA; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS NUCLEOPROTEIN; CAPSID PROTEIN; INTERLEUKIN DERIVATIVE; MUTANT PROTEIN; NUCLEOCAPSID PROTEIN, LASSA VIRUS;

AMINO ACID SUBSTITUTION; ANTIGEN PRESENTING CELL; ARENAVIRUS INFECTION; ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRANULATION; DENDRITIC CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LASSA VIRUS INFECTION; LYMPHOCYTE ACTIVATION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; UPREGULATION; ANIMAL; CELL CULTURE; CELL SURVIVAL; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LASSA VIRUS; MISSENSE MUTATION; SECRETION (PROCESS);

LASSA VIRUS;

ANIMALS; ANTIGEN-PRESENTING CELLS; CAPSID PROTEINS; CELL DEGRANULATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; EXONUCLEASES; HUMANS; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKINS; KILLER CELLS, NATURAL; LASSA VIRUS; MACROPHAGES; MUTANT PROTEINS; MUTATION, MISSENSE;

EID: 84911399835     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01908-14     Document Type: Article

References (35)

1. McCormick J. 1987. A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis. 155:437-444. http://dx.doi.org/10.1093/infdis/155 .3.437.
2. Fisher-Hoch S, Hutwagner L, Brown B, McCormick J. 2000. Effective vaccine for Lassa fever. J. Virol. 74:6777-6783. http://dx.doi.org/10.1128 /JVI.74.15.6777-6783.2000.
3. Buchmeier M, de la Torre J-C, Peters C. 2007. Arenaviridae: the viruses and their replication, p 1791-1827. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
4. Martinez-Sobrido L, Emonet S, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC. 2009. Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 83:11330-11340. http://dx .doi.org/10.1128/JVI.00763-09.
5. Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC. 2007. Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J. Virol. 81:12696-12703. http://dx.doi.org/10 .1128/JVI.00882-07.
6. Martinez-Sobrido L, Zuniga EI, Rosario D, Garcia-Sastre A, de la Torre JC. 2006. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 80:9192-9199. http://dx.doi.org/10.1128/JVI.00555-06.
7. Qi X, Lan S, Wang W, Schelde L, Dong H, Wallat G, Ly H, Liang Y, Dong C. 2010. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468:779-783. http://dx.doi.org/10.1038 /nature09605.
8. Hastie K, Kimberlin C, Zandonatti M, MacRae I, Saphire E. 2011. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3= to 5= exonuclease activity essential for immune suppression. Proc. Natl. Acad. Sci. U. S. A. 108:2396-2401. http://dx.doi.org/10.1073/pnas.1016404108.
9. Jiang X, Huang Q, Wang W, Dong H, Ly H, Liang Y, Dong C. 2013. Structures of arenaviral nucleoproteins with triphosphate dsRNA reveal a unique mechanism of immune suppression. J. Biol. Chem. 288:16949- 16959. http://dx.doi.org/10.1074/jbc.M112.420521.
10. Hastie KM, Bale S, Kimberlin CR, Saphire EO. 2012. Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses. Curr. Opin. Virol. 2:151-156. http://dx.doi.org/10.1016/j.coviro .2012.01.003.
11. Baize S, Kaplon J, Faure C, Pannetier D, Georges-Courbot MC, Deubel V. 2004. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 172:2861-2869. http://dx .doi.org/10.4049/jimmunol.172.5.2861.
12. Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, Pulendran B. 2003. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol. 170:2797-2801. http://dx.doi .org/10.4049/jimmunol.170.6.2797.
13. Baize S, Pannetier D, Faure C, Marianneau P, Marendat I, Georges- Courbot MC, Deubel V. 2006. Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages. Microbes Infect. 8:1194-1202. http://dx.doi.org/10.1016/j.micinf.2006.02.002.
14. Pannetier D, Reynard S, Russier M, Journeaux A, Tordo N, Deubel V, Baize S. 2011. Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus. J. Virol. 85:8293-8306. http://dx.doi.org/10.1128/JVI.02120-10.
15. Russier M, Reynard S, Tordo N, Baize S. 2012. NK cells are strongly activated by Lassa and Mopeia virus-infected human macrophages in vitro but do not mediate virus suppression. Eur. J. Immunol. 42:1822-1832. http://dx.doi.org/10.1002/eji.201142099.
16. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189-220. http://dx.doi.org/10.1146 /annurev.immunol.17.1.189.
17. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, Sallusto F. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5:1260- 1265. http://dx.doi.org/10.1038/ni1138.
18. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195:327-333. http://dx.doi.org/10.1084/jem.20010938.
19. Carnec X, Baize S, Reynard S, Diancourt L, Caro V, Tordo N, Bouloy M. 2011. Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages. J. Virol. 85:12093-12097. http://dx.doi.org/10.1128/JVI.00429-11.
20. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keita S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traore A, Kolie M, Malano ER, Heleze E, Bocquin A, Mely S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Gunther S. 16 April 2014. Emergence of Zaire Ebola virus disease in Guinea-preliminary report. N. Engl. J. Med. http://dx.doi.org/10.1056 /NEJMoa1404505.
21. Pannetier D, Reynard S, Russier M, Carnec X, Baize S. 2014. Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with Lassa fever. PLoS Negl. Trop. Dis. 8:e2637. http: //dx.doi.org/10.1371/journal.pntd.0002637.
22. Baize S, Marianneau P, Loth P, Reynard S, Journeaux A, Chevallier M, Tordo N, Deubel V, Contamin H. 2009. Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected cynomolgus monkeys. J. Virol. 83:5890-5903. http: //dx.doi.org/10.1128/JVI.01948-08.
23. Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih HR. 2008. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. J. Immunol. 181:6711-6719. http://dx.doi.org/10.4049/jimmunol .181.10.6711.
24. Nedvetzki S, Sowinski S, Eagle RA, Harris J, Vely F, Pende D, Trowsdale J, Vivier E, Gordon S, Davis DM. 2007. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 109:3776-3785. http://dx.doi.org/10.1182/blood -2006-10-052977.
25. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223. http://dx.doi.org/10.1146/annurev.immunol.19.1.197.
26. Simhadri VR, Reiners KS, Hansen HP, Topolar D, Simhadri VL, Nohroudi K, Kufer TA, Engert A, Pogge von Strandmann E. 2008. Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PLoS One 3:e3377. http://dx.doi.org/10 .1371/journal.pone.0003377.
27. Matusali G, Tchidjou HK, Pontrelli G, Bernardi S, D'Ettorre G, Vullo V, Buonomini AR, Andreoni M, Santoni A, Cerboni C, Doria M. 2013. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. FASEB J. 27:2440-2450. http://dx.doi.org/10.1096/fj.12-223057.
28. Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat. Immunol. 1:70-76. http: //dx.doi.org/10.1038/76940.
29. Mack EA, Kallal LE, Demers DA, Biron CA. 2011. Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection. mBio 2(4):e00169- 11. http://dx.doi.org/10.1128/mBio.00169-11.
30. Borg C, Jalil A, Laderach D, Maruyama K, Wakasugi H, Charrier S, Ryffel B, Cambi A, Figdor C, Vainchenker W, Galy A, Caignard A, Zitvogel L. 2004. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104: 3267-3275. http://dx.doi.org/10.1182/blood-2004-01-0380.
31. Chaix J, Tessmer MS, Hoebe K, Fuseri N, Ryffel B, Dalod M, Alexopoulou L, Beutler B, Brossay L, Vivier E, Walzer T. 2008. Cutting edge: priming of NK cells by IL-18. J. Immunol. 181:1627-1631. http://dx.doi .org/10.4049/jimmunol.181.3.1627.
32. Zhou S, Cerny AM, Zacharia A, Fitzgerald KA, Kurt-Jones EA, Finberg RW. 2010. Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J. Virol. 84: 9452-9462. http://dx.doi.org/10.1128/JVI.00155-10.
33. Asper M, Sternsdorf T, Hass M, Drosten C, Rhode A, Schmitz H, Gunther S. 2004. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J. Virol. 78:3162-3169. http://dx.doi.org/10.1128/JVI.78.6.3162-3169.2004.
34. Rodrigo WW, Ortiz-Riano E, Pythoud C, Kunz S, de la Torre JC, Martinez-Sobrido L. 2012. Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. J. Virol. 86:8185-8197. http://dx.doi.org/10 .1128/JVI.07240-11.
35. Reynard S, Russier M, Fizet A, Carnec X, Baize S. 2014. Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response. J. Virol. 88:13923-13927. http: //dx.doi.org/10.1128/JVI.01923-14.